MADISON, Wis., Oct. 12, 2020 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today announced the introduction of the Oncotype MAP™ Pan-Cancer Tissue test for patients with advanced, metastatic, ...

GUARDANT HEALTH LAUNCHES GUARDANT360 TISSUE, FIRST TISSUE MOLECULAR PROFILING TEST WITH COMPREHENSIVE MULTIOMIC ANALYSIS TO PROVIDE A MORE COMPLETE VIEW OF CANCER Powered by Guardant Infinity smart ...

A head-to-head study pitting Guardant Health’s lung cancer blood test against standard, tissue-based testing found that the liquid biopsy was able to deliver similar results much faster and with more ...

It is often said that the most disruptive and world-shaping ideas don’t come from a bolt of insight but are, instead, the response to a rejection. The emerging field of tissue engineering followed ...

Please provide your email address to receive an email when new articles are posted on . A blood test to detect circulating tumor DNA accurately predicted recurrence of HPV-driven oropharyngeal cancer ...

Tara Biosystems is growing heart cells in a lab, which can then be given drugs and monitored for side effects, before putting the drugs in a living being. It looks like an elongated blob: a pulsating, ...

PALO ALTO, Calif., November 10, 2025--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the expansion of its Guardant Reveal® blood test to ...

Monday is shipping day at MatTek. A truck pulls up to its red brick lab outside of Boston to load box after box, all kept at a cool 39 degrees. The precious, perishable cargo is human skin---thousands ...

Powered by Guardant Infinity smart liquid biopsy platform, advanced multiomic test evaluates genomic, epigenomic and RNA-based molecular data First tissue comprehensive genomic profiling test to offer ...